Source: Annual Congress 2004 - The spectrum of approaches to molecular and cellular lung injury
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. N. Zelenskaya, T. Z. Seisembekov, S. B. Zhautikova, A. V. Bazarova, I. Y. Kozlova, E. V. Bjul (Astana, Karaganda, Kazakhstan). Content of total lipids in the exhaled breath condensate in type 1 diabetic mellitus patients with different level HbA1c. Eur Respir J 2004; 24: Suppl. 48, 3437

Member's Comments

No comment yet.

Related content which might interest you: The characteristic of exhaled breath condensate in patients with diabetes mellitus Source: Eur Respir J 2003; 22: Suppl. 45, 210s Year: 2003 Exhaled breath analysis in patients with diabetes mellitus using an electronic nose Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Increased of TNF-α Levels in breath condensate and in serum of COPD subjects Source: Eur Respir J 2003; 22: Suppl. 45, 448s Year: 2003 Effect of roflumilast (ROF) on glucose levels in patients with COPD and diabetes mellitus type 2 (DM2) Source: Annual Congress 2010 - COPD: management Year: 2010 Relationship of inflamamatory markers in blood and exhaled breath condensate in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006 N-acetylcysteine reduces 8-isoprostane levels in exhaled breath condensate and serum of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 13s Year: 2005 Elevated breath glucose is related to respiratory symptoms and not to disease type, control, duration or complications in diabetes mellitus patients Source: Eur Respir J 2007; 30: Suppl. 51, 365s Year: 2007 The relationship between lung function and blood glucose control in type 2 diabetic patients Source: Annual Congress 2008 - Lung function, airways and cough Year: 2008 Changes of intermediate substrates of carbohydrate metabolism in exhaled breath condensate (EBC) during COPD development Source: Eur Respir J 2005; 26: Suppl. 49, 439s Year: 2005 Screening for diabetes mellitus in patients with OSAS: a case for glycosylated haemoglobin Source: Eur Respir J 2012; 40: 273-274 Year: 2012 Increased lactate concentrations in exhaled breath condensate (EBC) in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007 TNF-α in exhaled breath condensate and in serum of scleroderma patients Source: Eur Respir J 2003; 22: Suppl. 45, 448s Year: 2003 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003 Apocynin reduces H2O2 and NO2¯ concentrations in exhaled breath condensate of COPD patients Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Increased exhaled breath temperature in subjects with non-controlled asthma Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control Year: 2010 Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Influence of smoking on indicators of free-radical oxidation in a condensate in exhaled breath condensate (EBC) at healthy and patients with bronchial asthma (BA) Source: Annual Congress 2010 - Smoking related disorders Year: 2010 Zinc and magnesium in serum and exhaled breath condensate of patients with obstructive lung diseases and healthy controls Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Relationship between sputum analysis, methacholine challenge testing and exhaled breath condensate pH in patients with mild-to-moderate well-controlled asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010